Imbruvica sales over time
This page will track the quarterly sales of Imbruvica over time, as reported by Johnson & Johnson's Janssen unit.
Note: Janssen and AbbVie co-market Imbruvica in the United States. Janssen markets it in EMEA (Europe, Middle East and Africa) and rest of the world. The companies share profits 50/50. The below figures represent sales only as reported by Johnson & Johnson during its quarterly earnings reports.
Who Am I?
I'm an individual investor from Kansas City. My focus is on biotech stocks, but I enjoy investing in all industries. I'm an old-school, buy and hold investor who believes the best way to outperform and grow capital is to own innovative companies with good management teams over the long-term. more>>>